|
1
|
Pouysségur J, Dayan F and Mazure NM:
Hypoxia signalling in cancer and approaches to enforce tumour
regression. Nature. 441:437–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Isa AY, Ward TH, West CM, Slevin NJ and
Homer JJ: Hypoxia in head and neck cancer. Br J Radiol. 79:791–798.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Janssen HL, Haustermans KM, Balm AJ and
Begg AC: Hypoxia in head and neck cancer: How much, how important?
Head Neck. 27:622–638. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Göttgens EL, Ostheimer C, Span PN, Bussink
J and Hammond EM: HPV, hypoxia and radiation response in head and
neck cancer. Br J Radiol. 14:201800472018.
|
|
6
|
Bredell MG, Ernst J, El-Kochairi I, Dahlem
Y, Ikenberg K and Schumann DM: Current relevance of hypoxia in head
and neck cancer. Oncotarget. 7:50781–50804. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kishimoto K, Yoshida S, Ibaragi S,
Yoshioka N, Okui T, Hu GF and Sasaki A: Hypoxia-induced
up-regulation of angiogenin, besides VEGF, is related to
progression of oral cancer. Oral Oncol. 48:1120–1127. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brennan PA, Mackenzie N and Quintero M:
Hypoxia-inducible factor 1alpha in oral cancer. J Oral Pathol Med.
34:385–389. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghani WMN, Ramanathan A, Prime SS, Yang
YH, Razak IA, Abdul Rahman ZA, Abraham MT, Mustafa WMW, Tay KK,
Kallarakkal TG, et al: Survival of oral cancer patients in
different ethnicities. Cancer Invest. 37:275–287. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Muñoz-Guerra MF, Fernández-Contreras ME,
Moreno AL, Martin ID, Herráez B and Gamallo C: Polymorphisms in the
hypoxia inducible factor 1-alpha and the impact on the prognosis of
early stages of oral cancer. Ann Surg Oncol. 16:2351–2358. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu L, Cash TP, Jones RG, Keith B,
Thompson CB and Simon MC: Hypoxia-induced energy stress regulates
mRNA translation and cell growth. Mol Cell. 21:521–531. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arsham AM, Howell JJ and Simon MC: A novel
hypoxia-inducible factor-independent hypoxic response regulating
mammalian target of rapamycin and its targets. J Biol Chem.
278:29655–29660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Foster KG and Fingar DC: Mammalian target
of rapamycin (mTOR): Conducting the cellular signaling symphony. J
Biol Chem. 285:14071–14077. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma XM and Blenis J: Molecular mechanisms
of mTOR-mediated translational control. Nat Rev Mol Cell Biol.
10:307–318. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Corradetti MN, Inoki K and Guan KL: The
stress-inducted proteins RTP801 and RTP801L are negative regulators
of the mammalian target of rapamycin pathway. J Biol Chem.
280:9769–9772. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ellisen LW, Ramsayer KD, Johannessen CM,
Yang A, Beppu H, Minda K, Oliner JD, McKeon F and Haber DA: REDD1,
a developmentally regulated transcriptional target of p63 and p53,
links p63 to regulation of reactive oxygen species. Mol Cell.
10:995–1005. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sofer A, Lei K, Johannessen CM and Ellisen
LW: Regulation of mTOR and cell growth in response to energy stress
by REDD1. Mol Cell Biol. 25:5834–5845. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brugarolas J, Lei K, Hurley RL, Manning
BD, Reiling JH, Hafen E, Witters LA, Ellisen LW and Kaelin WG Jr:
Regulation of mTOR function in response to hypoxia by REDD1 and the
TSC1/TSC2 tumor suppressor complex. Genes Dev. 18:2893–2904. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adel E, John C, Jennifert G, Takashi T and
Pieter S: WHO classification of head and neck tumoursIARC Press;
Lyon: pp. 105–131. 2017, PubMed/NCBI
|
|
22
|
National Comprehensive Cancer Network
(NCCN), . NCCN clinical practice guidelines in oncology-Head and
Neck cancers. NCCN Org. Version 2. 2018.
|
|
23
|
Wang N, Wang Q, Chi J, Xiang F, Lin M,
Wang W, Wei F and Feng Y: Carcinoembryonic antigen cell adhesion
molecule 1 inhibits the antitumor effect of neutrophils in tongue
squamous cell carcinoma. Cancer Sci. 110:519–529. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang N, Wang QJ, Feng YY, Shang W and Cai
M: Overexpression of chemerin was associated with tumor
angiogenesis and poor clinical outcome in squamous cell carcinoma
of the oral tongue. Clin Oral Investig. 18:997–1004. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang N, Feng Y, Wang Q, Liu S, Xiang L,
Sun M, Zhang X, Liu G, Qu X and Wei F: Neutrophils infiltration in
the tongue squamous cell carcinoma and its correlation with CEACAM1
expression on tumor cells. PLoS One. 9:e899912014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu MY, Huang PL, Ma Y, Ling SK, Li Y, Chen
BA and Xu YS: Effect of Redd1 loss on proliferation and metastasis
of pancreatic cancer cells with KrasG12D-LOH by inhibiting
glycolysis. J Clin Oncol (suppl). 35:2017.DOI:
10.1200/JCO.2017.35.15_suppl.e1574.
|
|
29
|
Dennis MD, McGhee NK, Jefferson LS and
Kimball SR: Regulated in DNA damage and development 1 (REDD1)
promotes cell survival during serum deprivation by sustaining
repression of signaling through the mechanistic target of rapamycin
in complex 1 (mTORC1). Cell Signal. 25:2709–2716. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang B, Liu GZ, Yang G, Mercado-Uribe I,
Huang M and Liu J: REDD1 is required for RAS-mediated
transformation of human ovarian epithelial cells. Cell Cycle.
8:780–786. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
DeYoung MP, Horak P, Sofer A, Sgroi D and
Ellisen LW: Hypoxia regulates TSC1/2-mTOR signaling and tumor
suppression through REDD1-mediated 14-3-3 shuttling. Gene Dev.
22:239–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yun SM, Woo SH, Oh ST, Hong SE, Choe TB,
Ye SK, Kim EK, Seong MK, Kim HA, Noh WC, et al: Melatonin enhances
arsenic trioxide-induced cell death via sustained upregulation of
Redd1 expression in breast cancer cells. Mol Cell Endocrinol.
422:64–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang B, Meng J, Zhu H, Du X, Sun L, Wang
L, Li S and Yang G: Overexpression of the recently identified
oncogene REDD1 correlates with tumor progression and is an
independent unfavorable prognostic factor for ovarian carcinoma.
Diagn Pathol. 13:872018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jia W, Chang B, Sun L, Zhu H, Pang L, Tao
L, Zou H, Du J, Dong Y, Qi Y, et al: REDD1 and p-AKT
over-expression may predict poor prognosis in ovarian cancer. Int J
Clin Exp Pathol. 7:5940–5949. 2014.PubMed/NCBI
|
|
35
|
Krock BL, Skuli N and Simon MC:
Hypoxia-induced angiogenesis: Good and evil. Genes Cancer.
2:1117–1133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang H, Kubica N, Ellisen LW, Jefferson LS
and Kimball SR: Dexamethasone represses signaling through the
mammalian target of rapamycin in muscle cells by enhancing
expression of REDD1. J Biol Chem. 281:39128–39134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
McGhee NK, Jefferson LS and Kimball SR:
Elevated corticosterone associated with food deprivation
upregulates expression in rat skeletal muscle of the mTORC1
repressor, REDD1. J Nutr. 139:828–834. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li XH, Ha CT, Fu D and Xiao M: REDD1
protects osteoblast cells from gamma radiation-induced premature
senescence. PLoS One. 7:e366042012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shoshani T, Faerman A, Mett I, Zelin E,
Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, et al:
Identification of a novel hypoxia-inducible factor 1-responsive
gene, RTP801, involved in apoptosis. Mol Cell Biol. 22:2283–2293.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Whitney ML, Jefferson LS and Kimball SR:
ATF4 is necessary and sufficient for ER stress-induced upregulation
of REDD1 expression. Biochem Biophys Res Commun. 379:451–455. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee M, Bikram M, Oh S, Bull DA and Kim SW:
Sp1-dependent regulation of the RTP801 promoter and its application
to hypoxia-inducible VEGF plasmid for ischemic disease. Pharm Res.
21:736–741. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shen X, Chang LG, Hu MY, Yan D, Zhou LN,
Ma Y, Ling SK, Fu YQ, Zhang SY, Kong B and Huang PL: KrasG12D-LOH
promotes malignant biological behavior and energy metabolism of
pancreatic ductal adenocarcinoma cells through the mTOR signaling
pathway. Neoplasma. 65:81–88. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zeng Q, Liu J, Cao P, Li J, Liu X, Fan X,
Liu L, Cheng Y, Xiong W, Li J, et al: Inhibition of REDD1
sensitizes bladder urothelial carcinoma to paclitaxel by inhibiting
autophagy. Clin Cancer Res. 24:445–459. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jin HO, Hong SE, Kim JH, Choi HN, Kim K,
An S, Choe TB, Hwang CS, Lee JH, Kim JI, et al: Sustained
overexpression of Redd1 leads to Akt activation involved in cell
survival. Cancer Lett. 336:319–324. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gong J, Zhou S and Yang S: Vanillic acid
suppresses HIF-1α expression via inhibition of mTOR/p70S6K/4E-BP1
and Raf/MEK/ERK pathways in human colon cancer HCT116 cells. Int J
Mol Sci. 20(pii): E4652019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tong WW, Tong GH and Liu Y: Cancer stem
cells and hypoxia-inducible factors (Review). Int J Oncol.
53:469–476. 2018.PubMed/NCBI
|
|
47
|
Ostergaard L, Tietze A, Nielsen T, Drasbek
KR, Mouridsen K, Jespersen SN and Horsman MR: The relationship
between tumor blood flow, angiogenesis, tumor hypoxia and aerobic
glycolysis. Cancer Res. 73:5618–5624. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ma T, Patel H, Babapoor-Farrokhran S,
Franklin R, Semenza GL, Sodhi A and Montaner S: KSHV induces
aerobic glycolysis and angiogenesis through HIF-1-dependent
upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Angiogenesis. 18:477–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Steinbichler TB, Alshaimaa A, Maria MV,
Daniel D, Herbert R, Jozsef D and Ira-Ida S: Epithelial-mesenchymal
crosstalk induces radioresistance in HNSCC cells. Oncotarget.
9:3641–3652. 2017.PubMed/NCBI
|
|
50
|
Chan N, Koritzinsky M, Zhao H, Bindra R,
Glazer PM, Powell S, Belmaaza A, Wouters B and Bristow RG: Chronic
hypoxia decreases synthesis of homologous recombination proteins to
offset chemoresistance and radioresistance. Cancer Res. 68:605–614.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Clavo B, Robaina F, Fiuza D, Ruiz A,
Lloret M, Rey-Baltar D, Llontop P, Riveros A, Rivero J, Castañeda
F, et al: Predictive value of hypoxia in advanced head and neck
cancer after treatment with hyperfractionated radio-chemotherapy
and hypoxia modification. Clin Transl Oncol. 19:419–424. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Carden CP, Stewart A, Thavasu P, Kipps E,
Pope L, Crespo M, Miranda S, Attard G, Garrett MD, Clarke PA, et
al: The association of PI3 kinase signaling and chemoresistance in
advanced ovarian cancer. Mol Cancer Ther. 11:1609–1617. 2012.
View Article : Google Scholar : PubMed/NCBI
|
